Company: MIRA
Filing Date: 2025-06-17
Form Type: PREM14A
Source: 0001641172-25-015340
Chunk: 162

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-06-17
Form: PREM14A
Chunk 162
---
 disclosures contained therein are intended only to qualify and limit the representations, warranties, and covenants of the subject Party of such Disclosure Schedule, as are contained in this Agreement. Matters reflected in the Disclosure Schedule are not necessarily limited to matters required by this Agreement to be reflected in such Disclosure Schedule.. Such additional matters are set forth for informational purposes and do not necessarily include other matters of a similar nature.

8.13 Counterparts. This Agreement may be executed in one or more counterparts, all of which shall be considered one and the same agreement and shall become effective when one or more counterparts have been signed by each of the Parties to this Agreement and delivered to the other Parties hereto. Any such counterpart delivered as a .pdf, .tif, .gif, .jpeg or similar attachment by electronic mail or by electronic signature delivered by electronic transmission (any such delivery, “ Electronic Delivery”) shall be treated in all manner and respects as an original executed counterpart and shall be considered to have the same binding legal effect as if it were the original signed version thereof delivered in person. No Party hereto shall raise the use of Electronic Delivery to deliver a counterpart or signature, or the fact that any counterpart or signature was transmitted or communicated through the use of Electronic Delivery, as a defense to the formation of a contract, and each Party hereto forever waives any such defense, except to the extent such defense relates to lack of authenticity.

<div align='center'>[Signature pages follow]</div>

| 47 |

IN WITNESS WHEREOF, each of the Parties has caused this Agreement and Plan of Merger to be duly executed on its behalf as of the day and year first above written.

| COMPANY               |                   |
| MIRA                  
 PHARMACEUTICALS, INC. |                   |
| By                    | /s/               
 Erez Aminov       |
| Name:                 | Erez              
 Aminov            |
| Title:                | Chief             
 Executive Officer |

| SUBSIDIARY       |             |
| MIRAPHARM        
 ACQUISITION INC. |             |
| By               | /s/         
 Erez Aminov |
| Name:            | Erez        
 Aminov      |
| Title:           | President   |

| SKNY                  
 PHARMACEUTICALS, INC. |                 |
| By                    | /s/             
 Kelly Stackpole |
| Name:                 | Kelly           
 Stackpole       |
| Title:                | CEO             |

<div align='center'>[Signature page